BASEL, Switzerland, November 21, 2008 - Basilea Pharmaceutica Ltd. announces that Zevtera(TM) (ceftobiprole medocaril), the first-in-class anti-MRSA broad-spectrum cephalosporin, received a positive opinion from the Committee for Medicinal Products ...
Read more...
To supplement or not to supplement - that is the question facing health-conscious consumers. Confronted with rows of glistening products in the high street and bombarded with persuasive messages from advertising hoardings, how are they to know ...
Read more...
Organisers of the 2009 WPS Bathurst 12-Hour Showroom Enduro are pleased to welcome back Arthritis Australia as its official charity for the third year in a row. Arthritis Australia is the peak arthritis organisation in Australia. It is supported by ...
Read more...
Antiangiogenic Role Of 2ME2 Demonstrated In Rheumatoid Arthritis Models ACTEMRA Inhibited Progression Of Joint Damage In RA Patients Demonstrated ACTEMRA Significantly Reduced Signs, Symptoms Of Rheumatoid Arthritis Discovery Yields Potential Gout ...
Read more...
A free program, “The Many Faces of Arthritis” is scheduled for 6:30 p.m. Tuesday at HealthReach, 1705 S.E. Broadway in Albert Lea. Sponsored by Albert Lea Medical Center — part of Mayo Health System — and District 241 the session will be ...
Read more...
CEL-SCI Corporation (NYSE: CVM) announced the presentation of new rheumatoid arthritis data at the 6th annual GTCbio Vaccine Conference in Vienna, Va. The data, presented by Dr. Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology ...
Read more...
The Arthritis Foundation Eastern Pennsylvania Chapter, Lehigh Valley, honored several supporters Nov. 2 for their efforts to support a cure for arthritis as well as support those in Eastern Pennsylvania living with arthritis. Dennis Mooney, Lehigh ...
Read more...